Amneal Pharmaceuticals, Inc.
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2019 | -260.1% | -21.2% | -16.5% |
| FY2020 | 22.4% | 2.2% | 1.7% |
| FY2021 | 3.7% | 0.4% | 0.3% |
| FY2022 | -90.7% | -9.4% | -7.1% |
| FY2023 | -424.6% | -3.5% | -2.4% |
| FY2024 | 107.0% | -5.7% | -3.3% |
| FY2025 | -101.8% | 2.9% | 2.0% |
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2019 | -260.1% | -21.2% | -16.5% |
| FY2020 | 22.4% | 2.2% | 1.7% |
| FY2021 | 3.7% | 0.4% | 0.3% |
| FY2022 | -90.7% | -9.4% | -7.1% |
| FY2023 | -424.6% | -3.5% | -2.4% |
| FY2024 | 107.0% | -5.7% | -3.3% |
| FY2025 | -101.8% | 2.9% | 2.0% |